Angelita Rebollo

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Chronic Lymphocytic Leukemia

Genome Wide Association

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Heriberto Bruzzoni-Giovanelli, Habib Zouali, Mourad Sahbatou, Benjamin Maneglier, Jean-Michel Cayuela, Angelita Rebollo, Gustavo H Marín, Daniela Geromin, Carole Tomczak, Antonio Alberdi, Jean François Deleuze, Philippe Rousselot
Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients. Pharmaceutics 16 (6) (2024)
Heriberto Bruzzoni-Giovanelli, Habib Zouali, Mourad Sahbatou, Benjamin Maneglier, Jean-Michel Cayuela, Angelita Rebollo, Gustavo H Marín, Daniela Geromin, Carole Tomczak, Antonio Alberdi, Jean François Deleuze, Philippe Rousselot
Constitutional DNA Polymorphisms Associated with the Plasma Imatinib Concentration in Chronic Myeloid Leukemia Patients. Pharmaceutics 16 (6) (2024)
Gustavo H Marín, Samuel Murail, Laura Andrini, Marcela N Garcia, Severine Loisel, Pierre Tuffery, Angelita Rebollo
In Silico and In Vivo Studies of a Tumor-Penetrating and Interfering Peptide with Antitumoral Effect on Xenograft Models of Breast Cancer. Pharmaceutics 15 (4) (2023)
Gustavo H Marín, Samuel Murail, Laura Andrini, Marcela N Garcia, Severine Loisel, Pierre Tuffery, Angelita Rebollo
In Silico and In Vivo Studies of a Tumor-Penetrating and Interfering Peptide with Antitumoral Effect on Xenograft Models of Breast Cancer. Pharmaceutics 15 (4) (2023)
Gustavo H Marín, Samuel Murail, Laura Andrini, Marcela N Garcia, Severine Loisel, Pierre Tuffery, Angelita Rebollo
In Silico and In Vivo Studies of a Tumor-Penetrating and Interfering Peptide with Antitumoral Effect on Xenograft Models of Breast Cancer. Pharmaceutics 15 (4) (2023)
Gustavo H Marín, Samuel Murail, Laura Andrini, Marcela N Garcia, Severine Loisel, Pierre Tuffery, Angelita Rebollo
In Silico and In Vivo Studies of a Tumor-Penetrating and Interfering Peptide with Antitumoral Effect on Xenograft Models of Breast Cancer. Pharmaceutics 15 (4) (2023)
Lorena Simón-Gracia, Severine Loisel, Valeria Sidorenko, Pablo Scodeller, Christophe Parizot, Eric Savier, Tanguy Haute, Tambet Teesalu, Angelita Rebollo
Preclinical Validation of Tumor-Penetrating and Interfering Peptides against Chronic Lymphocytic Leukemia. Molecular pharmaceutics 19 (3) (2022)
Chang Zhi Dong, Heriberto Bruzzoni-Giovanelli, Yanhua Yu, Karim Dorgham, Christophe Parizot, Jean Marc Zini, Jean Yves Brossas, Pierre Tuffery, Angelita Rebollo
Identification of peptides interfering with the LRRK2/PP1 interaction. PloS one 15 (8) (2020)